31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models

British Journal of Cancer

Volumn 77, Issue 11, 1998, Pages 1752-1760

  Robinson, S P ^a   Van Den Boogaart, A ^a,c   Maxwell, R J ^a,d   Griffiths, J R ^a   Hamilton, E ^b   Waterton, J C ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c Aranea Consult BV   (Netherlands)

^d MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

2H magnetic resonance imaging; 31P magnetic resonance spectroscopy; Bioenergetics; Blood flow; Hypoxia

Indexed keywords

HYDRALAZINE; PHOSPHATE; DEUTERIUM; PHOSPHORUS 31;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL DIVISION; EXPERIMENTAL NEOPLASM; FEMALE; MALE; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD FLOW; BREAST CARCINOMA; DEUTERON NUCLEAR MAGNETIC RESONANCE; ENERGY TRANSFER; FIBROSARCOMA; LUNG CARCINOMA; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ANIMALS; CELL DIVISION; FEMALE; HYDRALAZINE; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PHOSPHATES;

EID: 0031597506     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.293     Document Type: Article

References (45)

1. Bhujwalla ZM (1988) P-31 Magnetic Resonance Spectroscopy in Cancer Therapy: a study using transplanted animal tumour models. PhD Thesis. London University.
2. Bhujwalla ZM, Tozer GM, Field SB, Maxwell RJ and Griffiths JR (1990a) The energy metabolism of RIF-1 tumours following hydralazine. Radiother Oncol 19: 281-291
3. 31P NMR spectroscopy. NMR Biomed 3: 178-183
4. 31P MRS: absolute concentrations, signal-to-noise and prior knowledge. NMR Biomed 8: 87-93
5. Burney IA, Maxwell RJ, Griffiths JR and Field SB (1992) Deuterium nuclear magnetic resonance imaging of the developmental pattern of tumour blood flow. In Angiogenesis: Key Principles - Science - Technology - Medicine, Steiner R, Weisz PB and Langer R. (eds), pp. 357-361. Birkhauser: Basle
6. Denekamp J (1992) The choice of experimental models in cancer research: the key to ultimate success or failure? NMR Biomed 5: 234-237
7. Dunn JF, Frostick S, Adams GE, Stratford IJ, Howells N, Hogan G and Radda GK (1989) Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological study. FEBS Lett 249: 343-347
8. 13C resonances. Biochim Biophys Acta 805: 104-116
9. 15O perfusion measurements in the RIF-1 murine tumor in vivo. Radiat Res 106: 122-131
10. Falk P (1982) Differences in vascular pattern between the spontaneous and the transplanted C3H mouse mammary carcinoma. Eur J Cancer Clin Oncol 18: 155-165
11. Field SB, Needham S, Burney IA, Maxwell RJ, Coggle JE and Griffiths JR (1991) Differences in vascular response between primary and transplanted tumours. Br J Cancer 63: 723-726
12. 31P-NMR studies of a human tumour in situ. Lancet 1: 1435-1436
13. Horsman MR, Christensen KL and Overgaard J (1992). Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure. Int J Radiat Oncol Biol Phys 22: 455-458
14. Horsman MR, Nordsmark M, Hoyer M and Overgaard J (1995) Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours. Br J Cancer 72: 1474-1478
15. Jain RK (1988) Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658
16. Jain RK and Ward-Hartley K (1984) Tumor blood flow - characterization, modifications, and role in hyperthermia. IEEE Trans Sonics Ultrason SU-31: 504-526
17. Jirtle RL (1988) Chemical modification of tumour blood flow. Int J Hyperthermia 4: 355-371
18. Kalmus J, Okunieff P and Vaupel P (1990) Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors. Cancer Res 50: 15-19
19. Larcombe-McDouall JB, Mattiello J, McCoy CL, Simpson NE, Seyedsadr M and Evelhoch JL (1991) Size dependence of regional blood flow in murine tumours using deuterium magnetic resonance imaging. Int J Radiat Biol 60: 109-113
20. Lilly MB, Katholi CR and Ng TC (1985) Direct relationship between high-energy phosphate content and blood flow in thermally treated murine tumors. J Natl Cancer Inst 75: 885-889
21. McCredie JA, Inch WR and Sutherland RM (1971) Differences in growth and morphology between the spontaneous C3H mammary carcinoma in the mouse and its syngeneic transplants. Cancer 27: 635-642
22. 19F magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 16: 925-929
23. Menke H and Vaupel P (1988) Effect of injectable or inhalational anesthetics and of neuroleptic, neuroleptanalgesic, and sedative agents on tumor blood flow. Radiat Res 114: 64-76
24. Moulder JE and Rockwell S (1984) Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10: 695-712
25. Negendank W (1992) Studies of human tumors by MRS: a review. NMR Biomed 5: 303-324
26. 31P NMR spectroscopy of in vivo tumors. J Magn Reson 49: 271-286
27. 31P magnetic resonance spectroscopy. Br J Cancer 74(suppl. XXVII): S232-S235
28. 31P NMR for non-invasive evaluation of tumor metabolic status. Int J Radiat Oncol Biol Phys 12: 793-799
29. 31P-nuclear magnetic resonance spectroscopy. J Natl Cancer Inst 80: 745-750
30. Ordidge RJ, Connelly A and Lohman JAB (1986) Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J Magn Reson 66: 283-294
31. 31P NMR. Proc Natl Acad Sci (USA) 80: 2748-2751
32. 31P NMR spectroscopy in vivo of two murine tumor lines with widely different fractions of radiobiologically hypoxic cells. Int J Radiat Biol 54: 635-649
33. 31P NMR spectroscopy measurements of human ovarian carcinoma xenografts: relationship to tumour volume, growth rate, necrotic fraction and differentiation status. Radiother Oncol 12: 315-326
34. Rowell KP, Flower MA, McCready VR, Cronin B and Horwich A (1990) The effects of single dose oral hydralazine on blood flow through human lung tumours. Radiother Oncol 18: 283-292
35. 31P MRS of tumour metabolism in anaesthetized vs conscious mice. NMR Biomed 7: 167-171
36. Steel GG (1977) Growth rate of tumours. In Growth Kinetics of Tumours, Steel GG (ed), pp. 5-55. Clarendon: Oxford
37. Thomlinson RH and Gray LH (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9: 539-549
38. Tozer GM, Bhujwalla ZM, Griffiths JR and Maxwell RJ (1989) Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradialion. Int J Radiat Oncol Biol Phys 16: 155-164
39. Twentyman PR, Brown JM, Gray JW, Franko AJ, Scoles MA and Kallman RF (1980) A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst 64: 595-604
40. Vaupel P, Kallinowski F and Okunieff P (1989a) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465
41. 2 tension measurements in a murine fibrosarcoma. Radiat Res 120: 477-493
42. Vaupel P, Schaefer C and Okunieff P (1994). Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi. NMR Biomed 7: 128-136
43. 31P NMR signals using the variable projection method and prior knowledge. Magn Reson Med 6: 92-98
44. Warren BA (1979) The vascular morphology of tumors. In Tumor Blood Circulation, Petersen III. (ed), pp. 1-47. CRC Press: Boca Raton, FL
45. 31P magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 22: 473-476